ScholarIQanswers from OpenAlex

Short sirolimus half‐life in pediatric renal transplant recipients on a calcineurin inhibitor‐free protocol

PaperCitations, authors & open-access status

Short sirolimus half‐life in pediatric renal transplant recipients on a calcineurin inhibitor‐free protocol is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Short sirolimus half‐life in pediatric renal transplant recipients on a calcineurin inhibitor‐free protocol have?

ScholarIQcitation count

Short sirolimus half‐life in pediatric renal transplant recipients on a calcineurin inhibitor‐free protocol has 71 citations in the OpenAlex counts ScholarIQ stores.

When was Short sirolimus half‐life in pediatric renal transplant recipients on a calcineurin inhibitor‐free protocol published?

ScholarIQyear

Short sirolimus half‐life in pediatric renal transplant recipients on a calcineurin inhibitor‐free protocol has 2004 year in the ScholarIQ index.

What is the open-access status of Short sirolimus half‐life in pediatric renal transplant recipients on a calcineurin inhibitor‐free protocol?

ScholarIQoa status

Short sirolimus half‐life in pediatric renal transplant recipients on a calcineurin inhibitor‐free protocol has green oa status in the ScholarIQ index.

What is the DOI of Short sirolimus half‐life in pediatric renal transplant recipients on a calcineurin inhibitor‐free protocol?

ScholarIQdoi

The DOI for Short sirolimus half‐life in pediatric renal transplant recipients on a calcineurin inhibitor‐free protocol is on the source record.

What is the PMID of Short sirolimus half‐life in pediatric renal transplant recipients on a calcineurin inhibitor‐free protocol?

ScholarIQpmid

The PMID for Short sirolimus half‐life in pediatric renal transplant recipients on a calcineurin inhibitor‐free protocol is on the source record.

What is the OpenAlex record for Short sirolimus half‐life in pediatric renal transplant recipients on a calcineurin inhibitor‐free protocol?

ScholarIQopenalex

The OpenAlex for Short sirolimus half‐life in pediatric renal transplant recipients on a calcineurin inhibitor‐free protocol is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial